|
| |
| | Growth Factors and Cytokines |
 | | Subsequent studies have demonstrated, however, that IGF-I has autocrine and paracrine activities in addition to the initially observed endocrine activities on bone. |  | | family of growth factors and associated signaling pathways can be found on the Signaling by Wnts and TGFs- |  | | Studies of human disorders as well as gene knock-out studies in mice show the prominent role for FGFs is in the development of the skeletal system and nervous system in mammals. |
|
http://web.indstate.edu/thcme/mwking/growth-factors.html
(2547 words)
|
|
| |
| | Insulin-like growth factor - Wikipedia, the free encyclopedia |
 | | Almost every cell in the human body is affected by IGF-1, especially cells in muscle, cartilage, bone, liver, kidney, nerves, skin, and lungs. |  | | IGFs are part of a complex system that cells use to communicate with their physiologic enviornment. |  | | While IGF-2 May be primarily fetal in action it is also essential for development and function of organs such as the brain, liver and kidney. |
|
http://en.wikipedia.org/wiki/Insulin-like_growth_factor
(651 words)
|
|
| |
| | Insulin-like growth factor 1 - Wikipedia, the free encyclopedia |
 | | Almost every cell in the human body is affected by IGF-I, especially cells in muscle, cartilage, bone, liver, kidney, nerves, skin, and lungs. |  | | In August, 2005, the FDA approved Increlex as replacement therapy for severe IGF-1 deficiency based on clinical trial data from 71 patients. |  | | IGF1 has been synthesized and used in therapeutic trials for several conditions including growth failure and diabetes. |
|
http://en.wikipedia.org/wiki/Insulin-like_growth_factor_1
(482 words)
|
|
| |
| | Insulin-Like Growth Factor 1 (IGF-1) |
 | | Carro E, Nuñez A, Busiguina S, Torres-Aleman I. Circulating insulin-like growth factor 1 mediates effects of exercise on the brain. |  | | Insulin-like growth factor-1: potential for treatment of motor neuronal disorders. |  | | Plasma insulin-like growth factor 1 and prostate cancer risk: a prospective study. |
|
http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/ins_0303.shtml
(637 words)
|
|
| |
| | News - Higher Circulating Concentrations of Insulin-Like Growth Factor-1 and Main Binding Protein Appear Associated ... |
 | | Current Perspectives on Primary Prophylaxis and Patient Risk Factors for Venous Thromboembolism in the Cancer Patient |  | | Higher concentrations of circulating total insulin-like growth factor (IGF)-1 appear associated with an increased risk of prostate and premenopausal breast cancers, while higher concentrations of IGF binding protein (IGFBP)-3 appear associated with premenopausal breast cancer. |  | | Higher Circulating Concentrations of Insulin-Like Growth Factor-1 and Main Binding Protein Appear Associated with Increased Risk of Common Cancers |
|
http://www.docguide.com/news/content.nsf/news/9DDB7D9025B4E7C485256E7F004D87B8
(556 words)
|
|
| |
| | Growth factor 1 - The insulin-like growth factor 1 receptor induces physiological |
 | | Both Hepatocyte Growth Factor (HGF) and Stromal-Derived Factor-1 Regulate the Metastatic Behavior of Human Rhabdomyosarcoma Cells, But Only HGF Enhances |  | | Insulin-like growth factor 1 (IGF1) was considered a potential candidate for the treatment of heart failure. |  | | Growth factor 1 - The insulin-like growth factor 1 receptor induces physiological |
|
http://factor.allinfosites.com/q/factor-growth-factor-1.htm
(610 words)
|
|
| |
| | Insulin-Like Growth Factor I (IGF-I) |
 | | Since Sm-C is decreased with malnutrition, its concentration provides an index with which to monitor therapy for food deprivation. |  | | Low values may be found with nonfunctioning pituitary tumors, with constitutional delay of growth and development and with anorexia nervosa. |  | | The Sm-C level does not distinguish pituitary dwarfism from constitutional delay of growth and development. |
|
http://www.labcorp.com/datasets/labcorp/html/chapter/mono/sr003600.htm
(506 words)
|
|
| |
| | ARUP: IGF-1 (Insulin-Like Growth Factor 1) |
 | | Insulin like growth factor (IGF-1, also referred to as somatomedin-C or Sm-C), is one of a class of peptides whose serum concentrations are regulated principally by human growth hormone (GH) and nutritional intake. |  | | (See also: Growth Hormone and IGF Binding Protein-3.) In humans, two of these peptides have been identified, IGF-1 and IGF-2. |  | | The anabolic and growth promoting effects mediated by the IGFs include cell proliferation and protein synthesis. |
|
http://www.aruplab.com/guides/clt/tests/clt_al3b.jsp
(384 words)
|
|
| |
| | IGF-1, Homeopathic Proving, Insulin-like Growth Factor |
 | | Heat internally and sensation of heat of the cheeks. |  | | Localized most frequently to the forehead, and also behind the eyes, above the root of the nose, or in the vertex. |  | | Pain quality was pressing as from a weight or like a band. |
|
http://www.biomedcomm.com/store/pi_igf1_proving.html
(1144 words)
|
|
|